Coeptis Therapeutics Announced an Acquisition and a New Divison Launch
Coeptis Therapeutics Holdings, Inc., a biopharmaceutical company specializing in innovative cell therapy platforms for cancer, autoimmune, and infectious diseases, proudly announces the completion of its acquisition of the NexGenAI Affiliates...